NASDAQ: DCPH       Deciphera Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
57.93   -1.04 (1.76%)  56.85 - 58.86  34,402


Avg Volume (4 weeks):325,585
4 Weeks Range:50.57 - 64.939
4 Weeks Price Volatility (%):
52 Weeks Range:33.10 - 71.11
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Deciphera Pharmaceuticals Inc is a biotechnology company, develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations are functioned through the region of US.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1929  3963  365  3139 

Top 10 Active Counters
 LK 1.38+1.38 
 BLRX 2.83+1.35 
 AAPL 109.13-6.19 
 NIO 30.765-1.225 
 OAS 0.155-0.014 
 SQQQ 25.39+2.03 
 TWTR 42.06-10.37 
 HTZ 1.780.00 
 GE 7.405+0.035 
 NOK 3.39+0.04